Nitric oxide synthase 3 genotypes and inflammatory markers in coronary artery disease patients

Thromb Haemost 2007; 97(04): 683
DOI: 10.1160/TH07-01-0013

Letters to the Editor

Schattauer GmbH

William Fergusson

¹Private practice, Rockville, Maryland, USA

References
1 Lekakis JP, Ikonomidis I, Tsibida M. et al. Genetic variations of the endothelial nitric oxide synthase gene are related to increased levels of C-reactive protein and macrophage-colony stimulating-factor in patients with coronary artery disease. Thromb Haemost 2006; 96: 520-528.
2 Nagassaki S, Sertorio JTC, Metzger IF. et al. eNOS gene T-786C polymorphism modulates atorvastatin-induced increase in blood nitrite. Free Radic Biol Med 2006; 41: 1044-1049.
3 Souza-Costa DC, Sandrim VC, Lopes LF. et al. Anti-inflammatory effects of atorvastatin: Modulation by the T-786C polymorphism in the endothelial nitric oxide synthase geneAtherosclerosis 2006; Epub ahead of print.
4 Sandrim VC, Coelho EB, Nobre F. et al. Susceptible and protective eNOS haplotypes in hypertensive black and white subjects. Atherosclerosis 2006; 186: 428-432.
5 Sandrim VC, de Syllos RWC, Lisboa HRK. et al. Endothelial nitric oxide synthase haplotypes affect the susceptibility to hypertension in patients with type 2 diabetes mellitus. Atherosclerosis 2006; 189: 241-246.
6 Sandrim VC, Yugar-Toledo JC, Desta Z. et al. Endothelial nitric oxide synthase haplotypes are related to blood pressure elevation, but not to resistance to antihypertensive drug therapy. J Hypertens 2006; 24: 2393-2397.
7 Marroni AS, Metzger IF, Souza-Costa DC. et al. Consistent interethnic differences in the distribution of clinically relevant endothelial nitric oxide synthase (eNOS) genetic polymorphisms. Nitric Oxide 2005; 12: 177-182.